CCND2 and megalencephaly: Thus, de novo mutations in CYCLIN D2—that produce a stable form of the protein—have been identified in individuals who have a rare overgrowth disorder named Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome (MPPH) (Mirzaa et al., 2014).